Michelle Bradney

Michelle Bradney currently serves as the Senior Vice President of Medical and Scientific Affairs at Certa Therapeutics, overseeing global medical affairs, clinical development, and regulatory programs, with successes including FDA and EMA orphan designations. Concurrently, Michelle is the Chief Operating Officer at OccuRx, focusing on the enhancement of operational systems and processes. Previous roles include Head of Medical Affairs at Medical Developments International, where global medical operations were managed across multiple regions, and Vice President of Medical Affairs at OncoSil Medical Ltd, leading global medical affairs and clinical trial designs. Earlier experience at Allergan involved managing clinical study conduct and staff development in the Asia Pacific region. Michelle holds a Peer-to-Peer Mentoring degree from Women on Boards and a Course Certificate in Corporate Governance from the Australian Institute of Company Directors.